BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/14/2019 10:31:21 AM | Browse: 313 | Download: 445
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Observational Study |
Article Title |
Feasibility and safety of cryoballoon ablation for atrial fibrillation in patients with congenital heart disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Sylvia Abadir, Victor Waldmann, Katia Dyrda, Mikael Laredo, Blandine Mondésert, Marc Dubuc and Paul Khairy |
Funding Agency and Grant Number |
|
Corresponding Author |
Paul Khairy, FRCPC, MD, PhD, Full Professor, Electrophysiology Service and Adult Congenital Heart Center, Montreal Heart Institute, Université de Montréal, 5000 Belanger St E, Montreal QC H1T 1C8, Canada. paul.khairy@umontreal.ca |
Key Words |
Congenital heart disease; Atrial fibrillation; Cryoballoon ablation; Pulmonary vein isolation; Catheter ablation |
Core Tip |
Whereas, a few studies have described radiofrequency ablation for atrial fibrillation (AF) in patients with congenital heart disease (CHD), herein we report the first case series of cryoballoon ablation. Ten patients with CHD, median age 57.9 years, underwent cryoballoon ablation and were followed for a median of 2.8 years. Pulmonary vein isolation was acutely successful in all. No major complication occurred. One year after a single procedure, 6 (60%) patients remained free from AF. In conclusion, cryoballoon ablation is feasible and appears to be safe, with an excellent acute success rate and modest 1-year freedom from recurrent AF. |
Citation |
Abadir S, Waldmann V, Dyrda K, Laredo M, Mondésert B, Dubuc M, Khairy P. Feasibility and safety of cryoballoon ablation for atrial fibrillation in patients with congenital heart disease. World J Cardiol 2019; 11(5): 149-158 |
|
Received |
|
2019-02-03 14:46 |
|
Peer-Review Started |
|
2019-02-11 01:35 |
|
To Make the First Decision |
|
2019-04-16 06:18 |
|
Return for Revision |
|
2019-04-17 08:10 |
|
Revised |
|
2019-04-19 02:04 |
|
Second Decision |
|
2019-05-10 08:21 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-05-14 10:31 |
|
Articles in Press |
|
2019-05-14 10:31 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-05-24 06:06 |
ISSN |
1949-8462 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345